Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Melanotan-1 with Coffee Safety: Cardiovascular Load Comparison

Systolic BP Increase 8–12 mmHg 5–8 mmHg 13–20 mmHg Additive effect exceeds either compound alone; individuals with baseline hypertension (>130/85) may breach 150 mmHg threshold Heart Rate Increase 8–15 bpm 3–6 bpm 11–21 bpm Combined elevation frequently pushes

This comparison does not assign a generated winner or score.

  • Systolic BP Increase
  • 8–12 mmHg
  • 5–8 mmHg
  • 13–20 mmHg
  • Additive effect exceeds either compound alone; individuals with baseline hypertension (>130/85) may breach 150 mmHg threshold
  • Heart Rate Increase
  • 8–15 bpm
  • 3–6 bpm
  • 11–21 bpm
  • Combined elevation frequently pushes resting HR above 100 bpm during first week of melanotan-1 use before receptor downregulation occurs
  • Duration of Effect
  • 6–8 hours
  • 4–6 hours
  • 6–8 hours overlapping window
  • Peak overlap occurs 2–4 hours post-injection if coffee consumed 30–90 minutes after administration
  • Mechanism
  • MC4R-mediated sympathetic activation
  • Adenosine receptor antagonism
  • Independent pathways converging on sympathetic tone
  • No direct pharmacokinetic interaction but convergent physiological endpoints
  • Tolerance Development
  • Minimal (receptor density stable)
  • Rapid (7–10 days)
  • Partial (caffeine only)
  • Caffeine tolerance does not reduce melanotan-1 cardiovascular response; combined load persists
More references

Related material